← Back to Search

STEPS Program for Autism

N/A
Recruiting
Led By Susan W White
Research Sponsored by University of Alabama, Tuscaloosa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 14
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the STEPS program, which helps young adults with autism learn important life skills for independence. It focuses on youth with autism who struggle more with jobs and education. The program aims to improve their ability to live independently by teaching self-awareness and decision-making skills.

Who is the study for?
This trial is for young people aged 16-25 with a confirmed diagnosis of Autism Spectrum Disorder (ASD). They must be on stable medication and have a caregiver willing to participate. It's not open to individuals with intellectual disabilities or those showing suicidal intent.
What is being tested?
The STEPS program, aimed at improving transitions for youth with ASD, is being tested in the community. The study will refine the program with stakeholder input before trialing it with about 25 participants to assess its feasibility and initial effectiveness.
What are the potential side effects?
Since this trial involves an educational program rather than a medical intervention, traditional physical side effects are not applicable. However, participants may experience stress or anxiety due to new routines or social interactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 14 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adult Functioning Scale
Rehabilitation Success

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: STEPSExperimental Treatment1 Intervention
All participants receive the STEPS intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STEPS
2014
N/A
~270

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Autism, particularly community-based interventions like the STEPS Program, focus on structured support systems that include educational and vocational training, social skills development, and individualized planning. These interventions aim to enhance functional independence and social integration for youth with Autism Spectrum Disorder (ASD). Understanding these mechanisms is crucial as they address the unique challenges faced by individuals with ASD during critical transition periods, such as moving from school to adulthood, thereby improving their overall quality of life.
Through the Looking Glass: A Scoping Review of Cinema and Video Therapy.Autism-Centered Therapy for Childhood Apraxia of Speech (ACT4CAS): A Single-Case Experimental Design Study.Statistical design and analysis in trials of proportionate interventions: a systematic review.

Find a Location

Who is running the clinical trial?

University of Alabama, TuscaloosaLead Sponsor
46 Previous Clinical Trials
17,553 Total Patients Enrolled
Susan W WhitePrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

STEPS Clinical Trial Eligibility Overview. Trial Name: NCT05581069 — N/A
Autism Research Study Groups: STEPS
Autism Clinical Trial 2023: STEPS Highlights & Side Effects. Trial Name: NCT05581069 — N/A
STEPS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05581069 — N/A
~7 spots leftby Dec 2025